COMPANY PROFILE

Applied StemCell

Explore full profile

Advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry

Milpitas, United StatesFounded 2008Biotech & Life Sciences

Valuation $50–100M Last recorded · 2016

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Applied StemCell

Applied StemCell, Inc. operates in the biotechnology sector, specializing in CRISPR-based genome editing and stem cell services. The company provides a range of services including the creation of genetically modified cell lines, animal models, and comprehensive preclinical studies. Applied StemCell serves clients in the pharmaceutical, biotechnology, and academic research sectors, focusing on cancer and stem cell research. The company generates revenue through custom service contracts, product sales, and licensing agreements. Their business model is centered around offering high-quality, tailored solutions to accelerate basic research and drug discovery. Key offerings include iPSC differentiation, antibody discovery, and neurotoxicity screening. Applied StemCell's market is global, with a strong emphasis on innovation and precision in genetic engineering.

Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2008
Headquarters: Milpitas, United States
Employees: 49
Open positions: 1
Dealroom signal: 66.2/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Oncology, DNA, Biomedical, Genetics and genomics, Packaging and Containers, Health Diagnostics, Spinout, Genome Engineering, Biotech and Pharma
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
BUYOUT✓Exit	Oct 2023	$0	—	QHP Capital	↗
SERIES D✓Equity / VC	Jun 2016	$19M	$76M	Ping An Ventures · Viventures · Hermed Capital	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Applied StemCell website traffic

Latest recorded traffic for Applied StemCell is 6.4K monthly website visits, down 83.2% over the last three months. Applied StemCell's team declined 7.5% over the past year.

Latest monthly visits6.4K 3-month web change-83.2% 1-year team growth-7.5%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Senior Product Marketing ManagerMilpitas, CA · Marketing & Communication · Aug 9, 2026 Business Development Senior Manager (West Coast)Milpitas, CA · Business Development · Jul 19, 2026

2 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PIPierianDxEnables clinical labs to deliver patient-specific diagnosis and treatments	St. Louis, United States	Acquired	32	$62M	$135M
EPEpigenomicsMolecular diagnostics company developing and manufacturing a pipeline of products for the diagnosis of cancer	San Diego, United States	Acquired
APAperiomicsGenomic sequencing and bioinformatics for infectious pathogen identification	United States	Operational
EGEmpire GenomicsLeader in the field of molecular diagnostic services for oncology diseases	Cheektowaga, United States	Acquired
GBGeneCast BiotechnologyIt is a Beijing cancer diagnosis company	Haidian, China	Operational
SGSinglera GenomicsA developer of 'liquid biopsy' analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA	San Diego, United States	Operational
CACareDxInnovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey	Brisbane, United States	Operational
CDCancerGuide DiagnosticsMolecular diagnostics company developing genomic-based clinical and pharmaceutical cancer tests and services	Durham, United States	Closed